|
Oraluxe® (Cefpodoxime
Proxetil) is an orally administered, extended spectrum semi-synthetic
antibiotic of the cephalosporin class, belonging to the third
generation.
The bactericidal activity of Oraluxe results from its inhibition
of cell wall synthesis. Cefpodoxime has a high degree of stability in
the presence of beta-lactamases, both penicillinases and cephalosporins
of gram-negative and gram-positive bacteria.
Oraluxe® is recommended in adults and in children (age 5 months
through 12 years) for treatment of the following infections:
- Tonsillitis, pharyngitis, sinusitis and otitis media.
- Acute, community acquired pneumonia, acute purulent bronchitis, acute
bacterial exacerbation of chronic obstructive bronchitis.
- Acute, uncomplicated urethra and cervical gonorrhea caused by (neisseria
gonorrhoeae).
- Acute, uncomplicated anorectal infections in women due to (neisseria
gonorrhoeae).
- Uncomplicated urinary tract infections (cystitis).
- Uncomplicated skin and skin structure infections.
______________________________________________________________________________________________
Aleppo Pharmaceutical Company (ALPHA) is Syria's leading
manufacturer and distributor of pharmaceutical products. Providing high
quality products according to GMP requirements; regulations and ISO 9002
(Quality Management System).
Syrian Pharmaceutical Industries, Middle East, Syria Pharmaceutical
Industry, pharmacy, Medicaments, medical, Drugs, arab pharmaceutical
manufacturing, pharmaceutical companies, pharmaceutical sales.
If you have any questions about Oraluxe® that have not been
answered on this site send us an email or call ALPHA Pharmaceutical
Industry at + 963-21-2122424.
Copyright © ALPHA – Aleppo Pharmaceutical Industries, Aleppo-Syria -
Oraluxe®. All rights reserved
Web Design by
Syrian Web Solutions |